Systematic Reviews
Copyright ©The Author(s) 2025.
Artif Intell Gastroenterol. Jun 8, 2025; 6(1): 108198
Published online Jun 8, 2025. doi: 10.35712/aig.v6.i1.108198
Table 2 Studies summarizing the role of artificial intelligence in response prediction and prognostication
No.
Title of study
Ref.
Sample size
Validation method
Key limitations
1Machine learning in gastrointestinal surgerySakamoto et al[31]N/AMixed internal and externalLack of detailed validation cohort; small sample sizes
2A histopathology-based AI system for genetic alteration screening in intrahepatic cholangiocarcinomaXiao et al[32]100+ patientsInternalSmall sample size, lack of external validation
3A nomogram based on a collagen feature SVM for predicting treatment response in rectal cancerJiang et al[33]200+ patientsExternalSingle-center data, limited generalizability
4A novel classification of intrahepatic cholangiocarcinoma phenotypes using MLTsilimigras et al[34]150+ patientsExternalLimited external validation in diverse populations
5AI system for pathologic outcome prediction in early gastric cancerLee et al[36]300+ patientsExternalLack of long-term follow-up data
6AI-based recognition model for colorectal liver metastases in intraoperative ultrasoundTakayama et al[37]100+ patientsExternalSingle-center validation, limited scalability
7Analysis of methionine metabolism and macrophage-related patterns in hepatocellular carcinomaWen et al[38]200+ patientsExternalRequires further clinical validation in diverse cohorts
8AI and ML predicting transarterial chemoembolization outcomesCho et al[39]100+ patientsMixed internal and externalInconsistent prediction performance across centers
9AI based on serum biomarkers predicts efficacy of lenvatinib in hepatocellular carcinomaHsu et al[40]100+ patientsInternalNeeds multi-center validation
10AI-enabled histological prediction of remission or activity in ulcerative colitisIacucci et al[41]150+ patientsExternalLack of long-term clinical outcomes, limited sample size
11AI for lymph node metastasis prediction in gastric cancerYan et al[42]500+ gastric cancer patientsExternalLimited multi-center validation, needs wider cohort testing
12AI in gastrointestinal cancers: Diagnostic, prognostic, and surgical strategiesNagaraju et al[43]N/AN/ALacks detailed validation or large cohorts
13AI in perioperative management of major gastrointestinal surgeriesSolanki et al[44]300+ patientsExternalLimited by single-center studies; needs broader cohort validation
14AI system to determine risk of colorectal cancer metastasisKudo et al[45]200+ patientsExternalValidation needed in multi-center settings
15AI-driven patient selection for preoperative portal vein embolizationKuhn et al[46]150+ patientsExternalRequires larger-scale studies to confirm findings
16Comparison of models for predicting quality of life after hepatocellular carcinoma surgeryChiu et al[47]100+ patientsMixed internal and externalLimited external validation and long-term data
17ML survival framework for pancreatic cancerWang et al[48]300+ pancreatic cancer patientsInternalLack of multi-center validation; small sample size
18Deep learning model for predicting hepatocellular carcinoma recurrenceLiu et al[86]200+ patientsExternalNeed for larger cohort validation